跳至主要内容
临床试验/NCT04596800
NCT04596800招募中3 期

Prehabilitation Plus Enhanced Recovery After Surgery Versus Enhanced Recovery After Surgery in Gynecologic Oncology: a Randomized Clinical Trial

Instituto Brasileiro de Controle do Cancer1 个研究点 分布在 1 个国家目标入组 194 人开始时间: 2020年11月5日最近更新:
适应症

试验速览

阶段
3 期
状态
招募中
入组人数
194
试验地点
1
主要终点
Postoperative recovery time

研究概览

简要总结

Prospective, interventionist, controlled and randomized study to test the effectiveness of a multimodal prehabilitation protocol in patients who will undergo gynecological surgery.

详细描述

Prospective, interventionist and randomized controlled trial in a 1: 1 ratio, open to multidisciplinary team and blind to surgeons and anaesthesiologists. The aim is test the effectiveness of a multimodal prehabilitation protocol in patients who will undergo gynecological surgery.

The multidisciplinary prehabilitation program will be applied to the intervention group. For the group participating in the prehabilitation and for the control group, specific recommendations for gynecological cancer defined by the Enhanced Recovery After Surgery (ERAS®) guidelines will be applied.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Supportive Care
盲法
Single (Investigator)

盲法说明

Single-Blind (surgeons and anesthesiologists)

入排标准

年龄范围
18 Years 至 80 Years(Adult, Older Adult)
性别
Female
接受健康志愿者

入选标准

  • Patients who sign the Informed Consent Form, indicating that they understand the study procedures and their purpose;
  • Women aged between 18 and 80 years old;
  • Gynecological surgery performed by laparotomy;
  • Patients with Eastern Cooperative Oncology Group Performance Status of at least 2 (ECOG ≤2);
  • Preoperative schedule that allows prehabilitation intervention for 2 to 3 weeks

排除标准

  • Patients under 18 or older than 80 years old;
  • Significant comorbidities, such as: neurological or musculoskeletal disorder, heart disease and / or respiratory failure that prohibit physical exercise;
  • Limitation of ambulation preventing the patient to perform physical exercises;
  • Cognitive deterioration or patients with psychiatric disorder that prevents adherence to the program;
  • Emergency or urgency surgeries;
  • Surgeries by minimally invasive approach (laparoscopy or robotics);
  • Vulvectomy or soft tissue surgery without abdominal approach;
  • Minor gynaecological surgeries such as conizations;
  • Surgeries performed together with other specialties, in which the gynecology team is not primarily responsible for postoperative care;
  • If surgery is performed 21 days after the last day of the prehabilitation program, for any reason

结局指标

主要结局

Postoperative recovery time

时间窗: Up to 30 postoperative days

Postoperative day patient is ready for discharge, defined as the day the patient has the ability to walk alone, take care of herself, and ingest at least 75% of the daily caloric needs

次要结局

  • Complications and Adverse Effects(Up to 30 postoperative days)
  • Readmissions(Up to 30 postoperative days)
  • Health-related Quality of Life(At Baseline, the week before surgery, then at postoperative days 7, 30 and 60)
  • Intensive Care Unit admission rates(Up to 30 postoperative days)
  • Compliance to the ERAS® program guideline(Up to 30 postoperative days)
  • Changes in anxiety and depression from baseline(At Baseline, the week before surgery, then at postoperative days 7, 30 and 60)
  • Changes in functional capacity from baseline(At Baseline, the week before surgery, then at postoperative days 30 and 60)
  • Change in muscle strength(At Baseline, the week before surgery, then at postoperative days 30 and 60)
  • Change in body mass(At Baseline, the week before surgery, then at postoperative days 30 and 60)
  • Hospital stay(Up to 30 days)
  • Use of opioids in acute postoperative pain(Up to 30 days)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

André Lopes

MD

Instituto Brasileiro de Controle do Cancer

研究点 (1)

Loading locations...

相似试验